Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Review Which Crypto Strategies Are Low Risk, focusing on capital preservation, diversification, and disciplined rebalancing.
27,831 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
When the world's biggest ethereum treasury buys the dip, it grabs headlines—and raises questions for everyday investo...
DBA closed $68 million for its second venture fund on Feb. 18, 2026, signaling sustained appetite for crypto infrastr...
Six Republican senators warn Basel’s 1,250% risk weight could lock banks out of Bitcoin, a hurdle as Congress debates...
New analysis shows the Trump family generated roughly $2.3 billion in pretax crypto income from late 2024 through Apr...
If you’ve got $4,000, deciding between Dogecoin and Solana can feel overwhelming. This guide breaks down real-world u...
A wave of AI megadeals is poised to flood U.S. markets this year, with OpenAI, SpaceX and Anthropic planning massive ...
Bitcoin climbs as a tentative Iran peace framework sparks risk-on buying. Japan's ETF market shows steady inflows, wh...
A major alliance between Mastercard and Ripple signals a potential price move for XRP in 2026. This article breaks do...
When digital assets are seized, custody rules matter as much as the seizure itself. This article breaks down what hap...
Cryptocurrencies attract big headlines and big hopes. This guide takes a calm, practical look at XRP and shows you a ...
A growing cohort of Bitcoin veterans is converting crypto gains into hardened security, from armored vehicles to unde...